CSL to complete contracted manufacture of AstraZeneca vaccines in 2022

CSL has confirmed it will continue manufacturing AstraZeneca’s Covid-19 vaccine into next year, following reports it would cease production early due to local preferences for the Pfizer and Moderna vaccines. The full contract with the federal government to produce approximately 50 million doses of Vaxzevria will be met, with any unused doses donated to countries…

Woodside and 1414 degrees to develop silicon energy storage

Energy storage developer 1414 Degrees has signed agreements with Woodside Energy Technologies to support further development and potential partnership in the future commercialisation of 14D’s SiBox silicon energy storage technology. 1414 Degrees have been working with Woodside to establish a suitable validation project that will assess the commercial potential of 14D’s thermal energy storage technology,…

EOS’s bold move to lead in satellite data communications

Analysis by Peter Roberts The announcement by defence, space and communications manufacturer Electro Optic Systems that it is to spend US$300 million building four communications satellites is an extraordinarily bold move for an Australian technology company. But it it the culmination of decades of quiet research and development and careful corporate-building which has put the…

Seeley wins major meat works air con project

Australia’s largest air-conditioning manufacturer, Seeley International, will utilise its unique indirect evaporative cooling products to provide the HVAC system for Thomas Foods International’s new Murray Bridge meat-processing facility in South Australia which will replace one destroyed by fire. Seeley will provide its Climate Wizard indirect evaporative cooling systems (IEC, below) for the project which are…

Monash University and IDT to enter mRNA manufacturing

IDT Australia will go ahead with manufacturing an mRNA vaccine developed by Monash University as the long awaited technology finally reaches Australian shores. The basic technology behind the Pfizer and Moderna Covid-19 vaccines will be used by the Melbourne pharmaceutical manufacturer to make a vaccine candidate developed by the university’s Institute of Pharmaceutical Sciences (MIPS).…